EP3797296
HER2 HETEROGENEITY AS A BIOMARKER IN CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.5.2019EP published:
4.9.2024EP application number:
19727597.7
EPO information:
European Patent Register
Max expiry date:
19.5.2039
Title in English:
HER2 HETEROGENEITY AS A BIOMARKER IN CANCERLanguage of the patent:
English
Timeline
Today
20.5.2019EP application
4.9.2024EP Publication
Owner
Name:
GENENTECH, INC.Address:
1 DNA Way, South San Francisco, CA 94080, US
Name:
Ventana Medical Systems, Inc.Address:
1910 E. Innovation Park Drive, Tucson, Arizona 85755, US
Name:
National Cancer CenterAddress:
5-1-1, Tsukiji Chuo-ku, Tokyo 104-0045, JP
Inventor
Name:
MURILLO, Adrian E.Address:
Tucson, Arizona 85755, US
Name:
NITTA, HiroAddress:
Tucson, Arizona 85755, US
Name:
MUNROE, Donald G.Address:
Tucson, Arizona 85755, US
Name:
LO, Amy A.Address:
South San Francisco, California 94080, US
Name:
KUWATA, TakeshiAddress:
Kashiwa, 277-8577, JP
Name:
KAITO, AkioAddress:
Kashiwa, 277-8577, JP
Name:
OCHIAI, AtsushiAddress:
Kashiwa, 277-8577, JP
Priority
Number:
201862674566 PDate:
21.5.2018Country:
US
Classification
Categories:
G01N 33/574